2,125
Views
6
CrossRef citations to date
0
Altmetric
Articles

Palliative MRI-guided transurethral ultrasound ablation for symptomatic locally advanced prostate cancer

ORCID Icon, , , , ORCID Icon, , , , & show all
Pages 481-486 | Received 01 May 2020, Accepted 20 Aug 2020, Published online: 08 Sep 2020

References

  • Heidenreich A, Porres D, Pfister D. The role of palliative surgery in castration-resistant prostate cancer. Oncol Res Treat. 2015;38(12):670–677.
  • Marszalek M, Ponholzer A, Rauchenwald M, et al. Palliative transurethral resection of the prostate: functional outcome and impact on survival. BJU Int. 2007;99(1):56–59.
  • Crain DS, Amling CL, Kane CJ. Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer. J Urol. 2004;171(2):668–671.
  • Pelletier J, Cyr S, Julien A, et al. Contemporary outcomes of palliative transurethral resection of the prostate in patients with locally advanced prostate cancer. Urol Oncol-Semin Ori. 2018;36(8):363.
  • Gnanapragasam VJ, Kumar V, Langton D, et al. Outcome of transurethral prostatectomy for the palliative management of lower urinary tract symptoms in men with prostate cancer. Int J Urol. 2006;13(6):711–715.
  • Cameron MG, Kersten C, Vistad I, et al. Palliative pelvic radiotherapy for symptomatic incurable prostate cancer–a prospective multicenter study. Radiother Oncol. 2015;115(3):314–320.
  • Din OS, Thanvi N, Ferguson CJ, et al. Palliative prostate radiotherapy for symptomatic advanced prostate cancer. Radiother Oncol. 2009;93(2):192–196.
  • Pfister D, Porres D, Epplen R, et al. [Palliative radical (cysto)prostatectomy in locally advanced castration-resistant prostate cancer]. Urologe A. 2011;50(9):1101–1105.
  • Bechis SK, Carroll PR, Cooperberg MR. Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol. 2011;29(2):235–241.
  • Hehemann MC, Baldea KG, Quek ML. Prostate cancer in the elderly male: diagnostic and management considerations. Curr Geri Rep. 2017;6(3):133–138.
  • Anttinen M, Mäkelä P, Suomi V, et al. Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer. Scan J Urol. 2019;53(5):295–302.
  • Klotz L, Penson D, Chin J, et al. LBA20 MRI-guided transurethral ultrasound ablation (TULSA) in patients with localized prostate cancer: preliminary results of tact pivotal study. J Urol. 2018;199:1077–1078.
  • Chin JL, Billia M, Relle J, et al. Magnetic resonance imaging–guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: a prospective phase 1 clinical trial. Eur Urol. 2016;70(3):447–455.
  • Pereira K, HAlpern JA, McClure TD, et al. Role of prostate artery embolization in the management of refractory haematuria of prostatic origin. BJU Int. 2016;118(3):359–365.
  • Chen J-W, Shin JH, Tsao T-F, et al. Prostatic arterial embolization for control of hematuria in patients with advanced prostate cancer. J Vasc Interv Radiol. 2017;28(2):295–301.
  • Moreno JG, O'Hara SM, Long JP, et al. Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR. Urology. 1997;49(4):515–520.
  • Hanks GE, Leibel S, Kramer S. The dissemination of cancer by transurethral resection of locally advanced prostate cancer. J Urol. 1983;129(2):309–311.
  • Haidl F, Heidenreich A. The significance of palliative surgery in castration resistant prostate cancer. Aktuelle Urol. 2018;49(5):405–411.